Article Details

Roche gets EC nod for Phesgo to treat HER2-positive breast cancer

Retrieved on: 2020-12-24 10:18:45

Tags for this article:

Click the tags to see associated articles and topics

Roche gets EC nod for Phesgo to treat HER2-positive breast cancer. View article details on hiswai:

Excerpt

Phesgo integrates the same monoclonal antibodies as Perjeta and Herceptin with Halozyme Therapeutics' Enhanze drug delivery technology in a ...

Article found on: www.pharmaceutical-business-review.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo